Nantahala Capital Management, LLC Q1 2022 Filing

Filed May 13, 2022

Portfolio Value

$2.3T

Holdings

115

Report Date

Q1 2022

Filing Type

13F-HR

All Holdings (115 positions)

#StockSharesValue% PortfolioType
101
ELOXX PHARMACEUTICALS INC
774,767$434.0M0.02%
102
GLMDGALMED PHARMACEUTICALS LTD
258,957$412.0M0.02%
103
HTG MOLECULAR DIAGNOSTICS IN
285,963$397.0M0.02%
104
FINTECH ACQUISITION CORP V
333,331$317.0M0.01%
105
KINTARA THERAPEUTICS INC
663,279$264.0M0.01%
106
FALCON MINERALS CORP
674,561$256.0M0.01%
107
FINTECH ACQUISITION CORP VI
249,998$143.0M0.01%
108
GFAIGUARDFORCE AI CO LTD
374,205$142.0M0.01%
109
TCBWFTC BIOPHARM HOLDINGS PLC
235,294$117.0M0.01%
110
B RILEY PRINCIPAL 150 MERGER
120,686$109.0M0.00%
111
FTAC HERA ACQUISITION CORP
222,949$97.0M0.00%
112
INSU ACQUISITION CORP III
333,332$67.0M0.00%
113
METROMILE INC
507,460$66.0M0.00%
114
QUALTEK SERVICES INC
96,244$56.0M0.00%
115
OCGNOCUGEN INC
16,571$55.0M0.00%
PreviousPage 2 of 2